Pulmonary surfactant given prophylactically alleviates an asthma attack in guinea-pigs

Clinical and Experimental Allergy

Volumn 26, Issue 3, 1996, Pages 270-275

  Liu, M ^a,c   Wang, L ^a   Li, E ^a   Enhorning, G ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Airway inflammation; Airway resistance; Asthma; Pulsatile bubble surfactometer; Surfactant dysfunction; Surfactant prophylaxis

Indexed keywords

LUNG SURFACTANT; OVALBUMIN;

AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ARTICLE; ASTHMA; CONTROLLED STUDY; GUINEA PIG; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; LUNG FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST;

ANIMALS; ASTHMA; BLOOD GAS ANALYSIS; FORCED EXPIRATORY FLOW RATES; GUINEA PIGS; LUNG COMPLIANCE; MALE; OVALBUMIN; PULMONARY SURFACTANTS; TIDAL VOLUME;

EID: 0029875864     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00091.x     Document Type: Article

References (30)

1. Clements JA. Surface tension of lung extracts. Proc Soc Exp Biol Med 1957; 95:170-2.
2. Macklem PT, Proctor DF, Hogg JC. The stability of peripheral airways. Resp Physiol 1970; 8:191-203.
3. Kamm RD, Schroter RC. Is airway closure caused by a liquid film instability? Resp Physiol 1989; 75:141-56.
4. Yager D, Butler JB, Bastacky J et al. Amplification of airway constriction due to filling of airway interstices. J Appl Physiol 1989; 66:2873-84.
5. Liu M, Wang L, Li E, Enhorning G. Pulmonary surfactant will secure free airflow through a narrow tube. J Appl Physiol 1991; 71:742-8.
6. Enhorning G, Holm BA. Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube. J Appl Physiol 1993; 74:2922-7.
7. Liu M, Wang L, Enhorning G. Surfactant dysfunction develops when the immunized guinea-pig is challenged with ovalbumin aerosol. Clin Exp Allergy 1995; 25:1053-60.
8. Enhorning G, Duffy LC, Welliver RC. Pulmonary surfactant maintains patency of the rat's conducting airways. Am J Resp Crit Care Med 1995; 151:554-6.
9. Seeger W, Elssner A, Gunther A, Kramer H-J, Kalinowski HO. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity. Am J Respir Cell Mol Biol 1993; 9:213-20.
10. Ikegami M, Jobe A, Jacobs H, Lam R. A protein from airways of premature lambs that inhibits surfactant function. J Appl Physiol 1984; 57:1134-42.
11. Holm BA, Notter RH, Finkelstein JN. Surface property-changes from interactions of albumin with natural lung surfactant and extracted lung lipids. Chem Phys Lipids 1985; 38:287-98.
12. Fuchimukai T, Fujiwara T, Takahashi A, Enhorning G. Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 1987; 62:429-37.
13. Kurashima K, Ogawa H, Ohka T et al. A pilot study of surfactant inhalation for the treatment of asthmatic attack. Jpn J Allergol 1991; 40:160-3.
14. Dunn CJ, Elliott GA, Oostvee JA, Richards IM. Development of a prolonged eosinophil-rich inflammatory leukocyte infiltration in the guinea pig's asthmatic response to ovalbumin inhalation. Am Rev Respir Dis 1988; 137:541-7.
15. Popa V, Douglas JS, Bouhuys A. Airway responses to histamine, acetylcholine, and antigen in sensitized guinea pigs. J Lab Clin Med 1974; 84:225-34.
16. Metcalfe IL, Enhorning GE, Possmayer F. Pulmonary surfactant-associated proteins: their role in the expression of surface activity. J Appl Physiol 1980; 49:34-41.
17. Notter RH, Egan EA, Kwong MS, Holm BA, Shapiro DL. Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: effects of dose, dispersion technique, and gestational age. Pediatr Res 1985; 19:569-77.
18. Enhorning G, Shennan A, Possmayer F et al. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics 1985; 76:145-53.
19. Kwong MS, Egan EA, Notter RH, Shapiro DL. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics 1985; 76:585-92.
20. Kallos P, Kallos L. Experimental asthma in guinea pigs revisited. Int Archs Allergy Appl Immun 1984; 73:77-85.
21. Kawano O, Kohrogi H, Yamaguchi T, Araki S, Ando M. Neutral endopeptidase inhibitor potentiates allergic bronchoconstriction in guinea pigs in vivo. J Appl Physiol 1993; 75:185-90.
22. Andersson P. Antigen-induced bronchial anaphylaxis in actively sensitized guinea pigs. Allergy 1980; 35:65-71.
23. Becker G. Lung surfactant prevents allergic bronchial constriction in ovalbumin sensitized guinea pigs. BBA 1985; 44:K57-61.
24. Gross I, Ballard PL, Ballard RA, Jones CT, Wilson CM. Corticosteroid stimulation of phosphatidylcholine synthesis in cultured fetal rabbit lung. Endocrinology 1983; 112:829-37.
25. O'Reilly MA, Clark JC, Whitsett JA. Glucocorticoid enhances pulmonary surfactant protein B gene transcription. Am J Physiol 1991; 260:L37-43.
26. Phelps DS, Church S, Kourembaras S, Taeusch HW, Floros J. Increases in the 35kDa surfactant associated protein and its mRNA following in vivo dexamethasone treatment of fetal and neonatal rats. Electrophoresis 1987; 8:235-8.
27. Dobbs JG, Mason RJ. Pulmonary alveolar type II cells isolated from rats. Release of phosphatidylcholine in response to adrenergic stimulation. J Clin Invest 1979; 63:378-87.
28. Brown LAS, Longmore WJ. Adrenergic and cholinergic regulation of lung surfactant secretion in isolated perfused rat lung and in the alveolar type II cell in culture. J Biol Chem 1981; 256:66-72.
29. Ekelund L, Burgoyne R, Brymer D, Enhorning G. Pulmonary surfactant release in fetal rabbits as affected by terbutaline and aminophylline. Scand J Clin Lab Invest 1981; 41:237-45.
30. Jobe A, Ikegami M. Surfactant for the treatment of the respiratory distress syndrome. Am Rev Resp Dis 1987; 136:1256-75.